Explorer

The issuer used various models methodologies and assumptions to determine the estimate. The following deficiencies were identified: · The firm selected for testing certain controls that consisted of the review of certain methodologies and assumptions used by the issuer to determine the estimate. The firm did not evaluate the review procedures that the control owners performed including the procedures to identify items for follow up and the procedures to determine whether those items were appropriately resolved. (AS 2201.42 and .44)

The issuer used various models and assumptions to determine the estimate. The following deficiencies were identified: · The firm selected for testing controls that consisted of annual reviews and approvals of (1) the methodologies (2) new and revised models and (3) certain key inputs and assumptions used by the issuer to determine a portion of the estimate. Certain annual reviews and approvals of the methodologies and new and revised models did not operate during the current year and the firm tested instances of these controls which operated in the prior year. For certain of the controls over the methodologies new and revised models and certain key inputs and assumptions the firm did not evaluate the review procedures that the control owners performed including the procedures to identify items for follow up and procedures to determine whether those items were appropriately resolved. (AS 2201.42 and .44)

The firm selected for testing certain controls over the issuer's review of a significant estimate. The firm did not evaluate the review procedures that the control owners performed including the procedures to identify items for follow up and the procedures to determine whether those items were appropriately resolved. (AS 2201.42 and .44)

The issuer used various models and assumptions to determine the estimate. The firm selected for testing controls that consisted of the reviews and validations of certain models and assumptions used by the issuer to determine the estimate. The firm did not evaluate the review procedures that the control owners performed including the procedures to identify items for follow up and the procedures to determine whether those items were appropriately resolved. (AS 2201.42 and .44)

The issuer used various models and assumptions to determine the estimate. The following deficiencies were identified: · The firm selected for testing two controls that consisted of the review and approval of certain assumptions used by the issuer to determine the estimate. The firm did not evaluate the specific review procedures that the control owners performed to assess the reasonableness of the assumptions. (AS 2201.42 and .44)

The significant estimate consisted of multiple components that were valued by the issuer using various inputs assumptions models and methodologies. With respect to the components of the significant estimate the following deficiency was identified: • The firm selected for testing another control that consisted of the issuer's review of another input used by the issuer to estimate the valuation for the component. The firm did not (2) evaluate the specific review procedures that the control owners performed to evaluate the reasonableness of the input. (AS 2201.42 and .44)

The significant estimate consisted of multiple components that were valued by the issuer using various inputs assumptions models and methodologies. With respect to the components of the significant estimate the following deficiency was identified: • The firm selected for testing another control that consisted of the issuer's review of an element of the component including the reasonableness of the assumptions and methodology used to estimate the valuation for the element. The firm did not evaluate the specific review procedures that the control owner performed to evaluate the reasonableness of the assumptions and methodology used to estimate the valuation for the element. (AS 2201.42 and .44)

The significant estimate consisted of multiple components that were valued by the issuer using various inputs assumptions models and methodologies. With respect to the components of the significant estimate the following deficiency was identified: • The firm selected for testing a control that consisted of management's review and approval of certain models used by the issuer to estimate the valuation for the collective components. The firm did not (2) evaluate the specific review procedures that the control owners performed to evaluate the reasonableness of the models (AS 2201.42 and .44)

The significant estimate consisted of multiple components that were valued by the issuer using various inputs assumptions models and methodologies. With respect to the components of the significant estimate the following deficiency was identified: • The firm selected for testing other controls that consisted of the issuer's (1) review and validation of the methodologies used to develop certain assumptions used by the issuer to estimate the valuation for the collective components and (2) review and approval of the resulting assumptions. The firm did not evaluate the review procedures that the control owners performed including the procedures to identify items for follow-up and the procedures to determine whether those items were appropriately resolved. (AS 2201.42 and .44)

The significant estimate consisted of multiple components that were valued by the issuer using various inputs assumptions models and methodologies. With respect to the components of the significant estimate the following deficiency was identified: • The firm selected for testing another control that consisted of the issuer's review of certain other assumptions used by the issuer to estimate the valuations for the components. The firm did not evaluate the specific review procedures that the control owners performed to evaluate the reasonableness of the assumptions. (AS 2201.42 and .44)

For certain assets that were evaluated for impairment the issuer determined adjustment factors that were important inputs used in developing this estimate. The following deficiencies were identified: · The firm selected for testing controls that consisted of the issuer's review of this estimate including an assessment of these inputs for reasonableness. The firm did not evaluate the specific review procedures that the control owner performed to assess the reasonableness of these inputs. (AS 2201.42 and .44)

The firm selected for testing certain controls related to the issuer's reviews of a significant estimate. The firm did not evaluate the review procedures that the control owners performed including the procedures to identify items for follow up and the procedures to determine whether those items were appropriately resolved. (AS 2301.19 and .21)

The firm selected for testing a control that consisted of the issuer's review of certain data. The firm did not evaluate the review procedures that the control owner performed including the procedures to identify items for follow-up and the procedures to determine whether those items were appropriately resolved. (AS 2201.42 and .44).